Abstract: Provided are a method of ex-vivo culture of natural killer (NK) cells by treating the cells with a reactive oxygen species (ROS) inhibitor and/or a p53 protein inhibitor; and a composition comprising the cultured NK cells. By reducing the activity of ROS and p53 proteins during ex-vivo culture, NK cells may have achieved greater expansion efficiency without altering their anti-tumor cytotoxicity.

Abstract: The present invention relates to a non-aqueous electrolyte solution additive, and a non-aqueous electrolyte solution for a lithium secondary battery and a lithium secondary battery which comprise the same, wherein, specifically, since the non-aqueous electrolyte solution, which comprises a compound capable of maintaining a passive effect by increasing an effect of forming a solid electrolyte interface (SEI) on surfaces of a positive electrode and a negative electrode, is provided, high-temperature storage characteristics and life characteristics of the lithium secondary battery may be improved.

Abstract: The present invention relates to a method for the expansion and culture of natural killer cells. By using a method for the expansion and culture of natural killer cells, according to the present invention, the proliferation of human-derived natural killer cells is remarkably enhanced such that natural killer cells to be used for cancer treatment can be efficiently obtained.

Abstract: The present invention relates to an expansion culture method for natural killer cells and, more particularly, to an expansion culture method for natural killer cells, wherein the cultured natural killer cells are treated with an HDAC inhibitor. According to the present invention, when natural killer cells are subjected to in vitro expansion culture, the cells can be restrained from undergoing cell death, resulting in a remarkable improvement in the viability and production yield of the cells. Thus, natural killer cells, which are needed for cell therapy, such as cancer therapy, etc., can be obtained effectively.

Abstract: The present invention relates to an additive for a non-aqueous electrolyte solution, which may suppress the generation of metallic foreign matter causing a side effect in a battery while forming a stable film on the surface of an electrode, a non-aqueous electrolyte solution for a lithium secondary battery which includes the additive, and a lithium secondary battery including the non-aqueous electrolyte solution.

Abstract: A heterodimeric Fc-fused protein and a pharmaceutical composition comprising the heterodimeric Fc-fused protein are disclosed. The heterodimeric Fc-fused protein includes first and second Fc regions of an immunoglobulin heavy chain constant region (Fc) pair and in which IL-21 is bound to at least one of the N-terminus or the C-terminus of the first Fc region and/or the second Fc region, wherein CH3 domains of the first Fc region and the second Fc region are mutated such that the formation of a heterodimer is promoted. When the heterodimeric Fc-fused protein is used, an in vivo half-life of IL-21 included in the heterodimeric Fc-fused protein may be significantly increased.

Abstract: The present invention relates to a non-aqueous electrolyte solution for a lithium secondary battery, which includes a compound capable of suppressing an electrolyte solution side reaction in a high-temperature and high-voltage environment, and a lithium secondary battery in which cycle characteristics and stability are improved even during high-temperature and high-voltage charging by including the same.

Abstract: The present invention may improve the lifetime characteristics of a lithium secondary battery, and particularly, may provide a non-aqueous electrolyte solution or cathode including a phosphate-based compound which may exhibit stable and excellent lifetime characteristics at high temperature and high voltage regardless of the moisture content or the presence of a pressing process of the electrode.

Abstract: A heterodimeric Fc-fused protein and a pharmaceutical composition comprising the heterodimeric Fc-fused protein are disclosed. The heterodimeric Fc-fused protein comprises first and second Fc regions of an immunoglobulin heavy chain constant region (Fc) pair and in which IL-21 is bound to at least one of the N-terminus or the C-terminus of the first Fc region and/or the second Fc region, wherein CH3 domains of the first Fc region and the second Fc region are mutated such that the formation of a heterodimer is promoted. When the heterodimeric Fc-fused protein according to the present invention is used, an in vivo half-life of IL-21 included in the heterodimeric Fc-fused protein may be significantly increased.

Abstract: A non-aqueous electrolyte solution for a lithium secondary battery, and a lithium secondary battery including the same are disclosed herein. In some embodiments, a non-aqueous electrolyte solution includes a lithium salt, a non-aqueous solvent including a carbonate-based solvent and propyl propionate, and a compound represented by Formula 1. In some embodiments, the carbonate-based solvent is ethylene carbonate.

Abstract: The present disclosure refers to a secondary battery which comprises a high-voltage cathode active material and a separator whose pores are not obstructed even though being used together with the high-voltage cathode active material, thereby preventing the obstruction of pores in the separator and the formation of a dendrite in the anode and eventually providing good battery life performance.

Abstract: The present invention relates to a non-aqueous electrolyte additive, and a non-aqueous electrolyte for a lithium secondary battery including the same and a lithium secondary battery, and particularly, to a non-aqueous electrolyte additive having a nitrile group and a propargyl group, and a non-aqueous electrolyte for a lithium secondary battery and a lithium secondary battery, which include the non-aqueous electrolyte additive so that capacity and cycle lifespan characteristics at high temperature can be improved.

Abstract: The present invention relates to an additive for a non-aqueous electrolyte solution including a compound represented by Formula 1 below, a non-aqueous electrolyte solution for a lithium secondary battery including the same, and a lithium secondary battery including the non-aqueous electrolyte solution. NC—(R)n—CN??[Formula 1] (in Formula 1, R is a cycloalkylene group having 3 to 6 carbon atoms in which at least one cyano group (—CN) is substituted or unsubstituted, a haloalkylene group having 2 to 5 carbon atoms in which at least one cyano group (—CN) is substituted or unsubstituted, or an alkylene group having 2 to 5 carbon atoms in which at least one cyano group (—CN) is substituted, and n is an integer of 1 to 5.

Abstract: An electrolyte for a lithium secondary battery of the present invention may improve high-rate charge and discharge characteristics and high-temperature storage and life characteristics of a lithium secondary battery and may achieve an effect of increasing reversible capacity by simultaneously including lithium bis(fluorosulfonyl)imide (LiFSI) and a second lithium salt, as a lithium salt, while including a second additive as well as a novel borate-based lithium compound, as an additive.

Abstract: The present invention relates to a non-aqueous electrolyte solution for a lithium secondary battery, which includes a compound capable of suppressing an electrolyte solution side reaction in a high-temperature and high-voltage environment, and a lithium secondary battery in which cycle characteristics and stability are improved even during high-temperature and high-voltage charging by including the same.

Abstract: The present invention relates to a non-aqueous electrolyte solution for a lithium secondary battery which includes a compound acting as a HF scavenger, and a lithium secondary battery in which cycle life characteristics and high-temperature storage characteristics are improved by including the same.

Abstract: The present invention relates to an additive for a non-aqueous electrolyte solution, which may suppress the generation of metallic foreign matter causing a side effect in a battery while forming a stable film on the surface of an electrode, a non-aqueous electrolyte solution for a lithium secondary battery which includes the additive, and a lithium secondary battery including the non-aqueous electrolyte solution.

Abstract: The present invention relates to: a non-aqueous electrolyte additive comprising, as a substituent, at least one cyano group and/or at least one fluorine element; a non-aqueous electrolyte for a lithium secondary battery, comprising the same; and a lithium secondary battery including the non-aqueous electrolyte.

Abstract: The present invention relates to a non-aqueous electrolyte solution additive, and a non-aqueous electrolyte solution for a lithium secondary battery and a lithium secondary battery which comprise the same, wherein, specifically, since the non-aqueous electrolyte solution, which comprises a compound capable of maintaining a passive effect by increasing an effect of forming a solid electrolyte interface (SEI) on surfaces of a positive electrode and a negative electrode, is provided, high-temperature storage characteristics and life characteristics of the lithium secondary battery may be improved.

Abstract: A heterodimeric Fc-fused protein and a pharmaceutical composition comprising the heterodimeric Fc-fused protein are disclosed. The heterodimeric Fc-fused protein comprises first and second Fc regions of an immunoglobulin heavy chain constant region (Fc) pair and in which IL-21 is bound to at least one of the N-terminus or the C-terminus of the first Fc region and/or the second Fc region, wherein CH3 domains of the first Fc region and the second Fc region are mutated such that the formation of a heterodimer is promoted. When the heterodimeric Fc-fused protein according to the present invention is used, an in vivo half-life of IL-21 included in the heterodimeric Fc-fused protein may be significantly increased.